Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients

akronüüm: TIMESPAN
algus: 2021-04-01
lõpp: 2026-03-31
 
programm: H2020 - Horisont 2020
alaprogramm: HEALTH - Tervishoid, demograafilised muutused ja heaolu
instrument: RIA
projektikonkurss: H2020-SC1-2020-Single-Stage-RTD
projekti number: 965381
kestus kuudes: 60
partnerite arv: 17
 
lühikokkuvõte: TIMESPAN's main objective is to advance the management of patients with Attention Deficit Hyperactivity Disorders (ADHD) and co-occurring cardiometabolic disease by improving available treatments and risk stratification. Emerging evidence points at substa
partneri jrk nr ja roll partneri nimi riik kontaktisik koduleht
1 koordinaator OREBRO UNIVERSITY SE Henrik LARSSON www.oru.se
2 partner KAROLINSKA INSTITUTET SE www.ki.se
3 partner AARHUS UNIVERSITET DK www.au.dk
4 partner UNIVERSITETET I BERGEN NO www.uib.no
5 partner ACADEMISCH ZIEKENHUIS GRONINGEN NL www.umcg.nl
6 partner FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA ES http://www.vhir.org
7 partner KING'S COLLEGE LONDON UK www.kcl.ac.uk
8 partner TARTU ULIKOOL EE www.ut.ee
9 partner UNIVERSITY COLLEGE LONDON UK http://www.ucl.ac.uk
10 partner THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK US http://www.rfsuny.org
11 partner HASKOLI ISLANDS IS www.hi.is
12 partner UNIVERSITY OF NEW SOUTH WALES AU http://www.unsw.edu.au
13 partner THE UNIVERSITY OF HONG KONG HK www.hku.hk
14 partner ADD INFORMATION SERVICES UK www.addiss.co.uk
15 partner THE EUROPEAN ASSOCIATION FOR THE STUDY OF OBESITY - IRELAND COMPANY LIMITED BY GUARANTEE IE www.easo.org
16 partner EMPATICA SRL IT
17 partner Concentris Research Management GmbH DE www.concentris.de